Clinical trials
Terminated Phase 1 Anemia, Refractory, with Excess of Blasts trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 4 |
| 2009 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 1 |
| Incyte Corporation | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Magenta Therapeutics, Inc. | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
| Massachusetts General Hospital | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| New York Blood Center | 1 |
| Roncarolo, Maria Grazia, MD | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Refractory, with Excess of Blasts | 13 |
| Leukemia, Myeloid, Acute | 6 |
| Hodgkin Disease | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Myelodysplastic Syndromes | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Anemia, Refractory | 4 |
| Leukemia | 4 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 |
| Lymphoma, Non-Hodgkin | 4 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.